Skip to main content
Clinical Trials/NCT03661671
NCT03661671UnknownNot Applicable

Application of Linked Color Imaging(LCI) in Diagnosis of Early Gastric Cancer(EGC): a Multicenter,Prospective, Randomized Controlled Study

Changhai Hospital1 site in 1 country2,400 target enrollmentStarted: January 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
2,400
Locations
1
Primary Endpoint
Detection rate of gastric neoplastic lesion

Study Overview

Brief Summary

the purpose of this study is to evaluate application value of LCI in the diagnosis of early gastric cancer.

Detailed Description

The detection rate of early gastric cancer is still very low in China. The investigators need a new and effective screening method to improve the detection rate. LCI (linked-color imaging)is a new model of laser endoscopy which can provide brighter image. LCI can provide clear image which can make red part redder and white part whiter, so suspicious lesion could be found easier. The study of this randomized controlled trial is to discuss effectiveness of LCI in the diagnosis of early gastric cancer and to find a new method to improve the detection rate of early gastric cancer in China.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
40 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • High-risk group of gastric cancer: H. pylori infection; previously suffering from chronic atrophic gastritis, intestinal metaplasia, gastric ulcer, gastric polyps, residual stomach after surgery, hypertrophic gastritis, malignant anemia and other precancerous diseases of gastric cancer;
  • First degree relatives of patients with gastric cancer;
  • There are other high risk factors for gastric cancer (high salt, salted diet, smoking, heavy drinking, etc.).
  • Patients with early gastric cancer treated with endoscopic therapy (ESD, EMR).
  • The informed consent has been signed.

Exclusion Criteria

  • The TNM classification of cancer is consistent with those diagnosed by T2 above.
  • Patients with abnormal blood coagulation function or taking anticoagulants can not biopsy.
  • There were contraindications for gastroscopy.
  • A patient without self judgement;
  • Those who did not sign informed consent.
  • Previous gastroscopy has found suspicious lesions requiring careful examination.

Arms & Interventions

LCI+white light

Experimental

Using white light firstly to observe from cardia to duodenum and then switch LCI model to observe from antrum to cardia

Intervention: LCI+white light (Diagnostic Test)

White light

No Intervention

Using white light only.

Outcomes

Primary Outcomes

Detection rate of gastric neoplastic lesion

Time Frame: immediately following the procedure

Include early gastric caner,high grade dysplasia low grade dysplasia and adenoma

Secondary Outcomes

  • Sensitivity of detecting gastric neoplastic lesion(immediately following the procedure)
  • Specificity of detecting gastric neoplastic lesion(immediately following the procedure)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Zhaoshen Li

Director of Gastroenterology Dept

Changhai Hospital

Study Sites (1)

Loading locations...

Similar Trials